Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca

Jason Mast

Editor

Amber Tong

In an continued effort to monitor the effectiveness of its Covid-19 vaccine, Moderna has rolled out the latest slate of neutralization data against different variants …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca

Jason Mast

Editor

Amber Tong

Sign up to read this article for free.

WuXi AppTec will sell cell and gene therapy business to private equity firm

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CagriSema’s weight loss data disappointed. What does Novo do next?

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

CMS explains what went into its first round of drug price negotiations

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

Covid-19 roundup: Mod­er­na vac­cine kicks up an­ti­bod­ies against Delta vari­ant; UK study val­i­dates mix-and-match ap­proach for Pfiz­er-As­traZeneca

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca